Viswanath Devanarayan
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's disease.Viswanath Devanarayan, Kanta Horie, Kristin Wildsmith
|Sep 24, 2025
Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease.Viswanath Devanarayan, Michael C Donohue, Reisa A Sperling
|Mar 05, 2025
Predicted natural progression as an Alzheimer's prognostic covariate improves the precision of lecanemab efficacy assessments and clinical trial efficiency.Viswanath Devanarayan, Yuanqing Ye, Liang Zhu
|Nov 22, 2024
Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease.Viswanath Devanarayan, Arnaud Charil, Kanta Horie
|Jul 24, 2024
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairment.Viswanath Devanarayan, Daniel A Llano, Yan Helen Hu
|Jun 28, 2024
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.Viswanath Devanarayan, Thomas Doherty, Arnaud Charil
Pageof 2
